LENZ Therapeutics, Inc. (LENZ)

NASDAQ: LENZ · Real-Time Price · USD

19.15

-0.24 (-1.24%)

Jan 28, 2026, 12:27 PM EST - Market open

LENZ Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 28, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	599	794	-	-	-
Enterprise Value	398	578	-	-	-
Last Close Price	19.39	28.87	-	-	-
PB Ratio	2.86	3.89	-	-	-
P/TBV Ratio	3.09	3.89	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	-
Asset Turnover	0.08	-	-	0.46	-
Quick Ratio	12.46	20.09	3.55	4.68	14.61
Current Ratio	12.69	20.36	3.63	4.91	14.62
Return on Equity (ROE)	-28.78%	-38.94%	-157.61%	-39.80%	-
Return on Assets (ROA)	-19.52%	-25.64%	-77.17%	-20.07%	-
Return on Capital Employed (ROCE)	-34.90%	-28.60%	-139.70%	-28.00%	-39.20%
Earnings Yield	-9.83%	-6.27%	-	-	-
FCF Yield	-7.70%	-7.54%	-	-	-
Buyback Yield / Dilution	-87.55%	-986.27%	79.28%	-1.05%	-

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q